series	seriesDescription	geoAreaCode	geoAreaName	level	parentCode	parentName	type	X	Y	ISO3	UN_Member	Country_Profile	timeCoverage	geoInfoUrl	year	value	time_detail	upperBound	lowerBound	basePeriod	source	footnotes	nature_code	nature_desc	units_code	units_desc	reportingType_code	reportingType_desc	value_detail	lowerBound_detail	upperBound_detail
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	1	World	1			Region								2018	47.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	100	Bulgaria	4	151	Eastern Europe	Country	25.23763153	42.75731323	BGR	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	104	Myanmar	4	35	South-Eastern Asia	Country	96.51752295	21.19332882	MMR	1	1			2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	108	Burundi	5	14	Eastern Africa	Country	29.89080992	-3.366387428	BDI	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	11	Western Africa	4	202	Sub-Saharan Africa	Region								2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	116	Cambodia	4	35	South-Eastern Asia	Country	104.922836	12.71163737	KHM	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	12	Algeria	4	15	Northern Africa	Country	2.678164227	28.15940032	DZA	1	1			2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	120	Cameroon	5	17	Middle Africa	Country	12.7419827	5.692387031	CMR	1	1			2018	79.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	124	Canada	4	21	Northern America	Country	-101.6575058	57.72360191	CAN	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	13	Central America	4	419	Latin America and the Caribbean	Region								2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	135	Caucasus and Central Asia	1			Group								2018	74.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	14	Eastern Africa	4	202	Sub-Saharan Africa	Region								2018	77.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	140	Central African Republic	5	17	Middle Africa	Country	20.93559492	7.003720791	CAF	1	1			2018	47.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	142	Asia	2	1	World	Region								2018	26.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	143	Central Asia	3	142	Asia	Region								2018	71.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	145	Western Asia	3	142	Asia	Region								2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	15	Northern Africa	3	2	Africa	Region								2018	50.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	150	Europe	2	1	World	Region								2018	75.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	151	Eastern Europe	3	150	Europe	Region								2018	60.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	152	Chile	5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	154	Northern Europe	3	150	Europe	Region								2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	155	Western Europe	3	150	Europe	Region								2018	85.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	17	Middle Africa	4	202	Sub-Saharan Africa	Region								2018	68.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	170	Colombia	5	5	South America	Country	-73.07446751	3.888209046	COL	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	178	Congo	5	11	Western Africa	Country	15.22052612	-0.840544119	COG	1	1			2018	73.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	18	Southern Africa	4	202	Sub-Saharan Africa	Region								2018	74.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	180	Democratic Republic of the Congo	5	17	Middle Africa	Country	23.65496507	-2.877154732	COD	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	188	Costa Rica	5	13	Central America	Country	-84.19712782	9.970998683	CRI	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	19	Americas	2	1	World	Region								2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	196	Cyprus	4	145	Western Asia	Country	33.22285964	35.05659437	CYP	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	199	Least Developed Countries (LDC)	1			Group								2018	76.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	2	Africa	2	1	World	Region								2018	68.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	20	Andorra	4	39	Southern Europe	Country	1.576257417	42.54548611	AND	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	202	Sub-Saharan Africa	3	2	Africa	Region								2018	71.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	204	Benin	5	11	Western Africa	Country	2.339933594	9.65401646	BEN	1	1			2018	73.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	208	Denmark	4	154	Northern Europe	Country	9.326571283	56.03829721	DNK	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	21	Northern America	3	19	Americas	Region								2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	214	Dominican Republic	5	29	Caribbean	Country	-70.49847576	18.89832088	DOM	1	1			2018	70.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	218	Ecuador	5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1			2018	85.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	222	El Salvador	5	13	Central America	Country	-88.86862995	13.73603564	SLV	1	1			2018	75.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	231	Ethiopia	5	14	Eastern Africa	Country	39.63505296	8.631223181	ETH	1	1			2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	232	Eritrea	5	14	Eastern Africa	Country	38.11074289	16.12894644	ERI	1	1			2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	24	Angola	5	17	Middle Africa	Country	17.57817062	-12.33724746	AGO	1	1			2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	242	Fiji	4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	246	Finland	4	154	Northern Europe	Country	23.308447	61.91586738	FIN	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	250	France	4	155	Western Europe	Country	2.457288129	46.62660861	FRA	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	262	Djibouti	5	14	Eastern Africa	Country	42.18274707	11.56004161	DJI	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	268	Georgia	4	145	Western Asia	Country	43.3713615	42.04813028	GEO	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	270	Gambia	5	11	Western Africa	Country	-15.39944785	13.45295927	GMB	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	275	State of Palestine	4	145	Western Asia	Country	35.25694122	31.94347933	PSE	0	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	276	Germany	4	155	Western Europe	Country	10.3806066	51.08862743	DEU	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	288	Ghana	5	11	Western Africa	Country	-1.205623522	7.964825185	GHA	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	29	Caribbean	4	419	Latin America and the Caribbean	Region								2018	26.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	296	Kiribati	4	57	Micronesia	Country	-157.5643005	1.768837732	KIR	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	30	Eastern Asia	3	142	Asia	Region								2018	7.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	300	Greece	4	39	Southern Europe	Country	22.58307827	39.47301873	GRC	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	31	Azerbaijan	4	145	Western Asia	Country	50.01064725	40.39229544	AZE	1	1			2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	32	Argentina	5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	320	Guatemala	5	13	Central America	Country	-91.2312746	15.00273719	GTM	1	1			2018	85.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	328	Guyana	5	5	South America	Country	-58.97322037	4.788012784	GUY	1	1			2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	332	Haiti	5	29	Caribbean	Country	-72.33640958	18.40426539	HTI	1	1			2018	1.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	34	Southern Asia	3	142	Asia	Region								2018	28.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	340	Honduras	5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	348	Hungary	4	151	Eastern Europe	Country	19.41221519	47.1651448	HUN	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	35	South-Eastern Asia	3	142	Asia	Region								2018	23.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	352	Iceland	4	154	Northern Europe	Country	-19.02116966	64.79134763	ISL	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	356	India	4	34	Southern Asia	Country	79.3608464	22.34642074	IND	1	1			2018	6.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	36	Australia	4	53	Australia and New Zealand	Country	134.3499412	-25.57717202	AUS	1	1			2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	360	Indonesia	4	35	South-Eastern Asia	Country	113.9174	-0.994582204	IDN	1	1			2018	8.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	368	Iraq	4	145	Western Asia	Country	43.76606267	33.05013795	IRQ	1	1			2018	32.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	372	Ireland	4	154	Northern Europe	Country	-7.121425272	53.25274054	IRL	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	376	Israel	4	145	Western Asia	Country	34.62277992	31.06164552	ISR	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	380	Italy	4	39	Southern Europe	Country	12.57022427	42.79917282	ITA	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	384	CÃ´te d'Ivoire	5	11	Western Africa	Country	-5.552690016	7.62211586	CIV	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	39	Southern Europe	3	150	Europe	Region								2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	392	Japan	4	30	Eastern Asia	Country	139.2716103	36.6554539	JPN	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	398	Kazakhstan	4	143	Central Asia	Country	66.65359159	48.01963494	KAZ	1	1			2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	4	Afghanistan	4	34	Southern Asia	Country	66.02688198	33.83160199	AFG	1	1			2018	65.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	404	Kenya	5	14	Eastern Africa	Country	37.86096816	0.534797278	KEN	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	410	Republic of Korea	4	30	Eastern Asia	Country	127.8610254	36.45201023	KOR	1	1			2018	97.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	414	Kuwait	4	145	Western Asia	Country	47.49305029	29.53949468	KWT	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	417	Kyrgyzstan	4	143	Central Asia	Country	74.52324839	41.46204516	KGZ	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	418	Lao People's Democratic Republic	4	35	South-Eastern Asia	Country	101.9901968	20.27482773	LAO	1	1			2018	56.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	419	Latin America and the Caribbean	3	19	Americas	Region								2018	79.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	422	Lebanon	4	145	Western Asia	Country	35.89391711	33.92152458	LBN	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	426	Lesotho	5	18	Southern Africa	Country	28.25362195	-29.58041814	LSO	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	428	Latvia	4	154	Northern Europe	Country	26.42461876	56.64196636	LVA	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	430	Liberia	5	11	Western Africa	Country	-9.311879038	6.448381009	LBR	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	432	Landlocked developing countries (LLDCs)	1			Group								2018	72.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	434	Libya	4	15	Northern Africa	Country	18.0295985	27.04042819	LBY	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	44	Bahamas	5	29	Caribbean	Country	-78.05111663	24.69546597	BHS	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	440	Lithuania	4	154	Northern Europe	Country	23.90517807	55.33680309	LTU	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	442	Luxembourg	4	155	Western Europe	Country	6.092656563	49.77679538	LUX	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	450	Madagascar	5	14	Eastern Africa	Country	46.6982339	-19.38514785	MDG	1	1			2018	75.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	454	Malawi	5	14	Eastern Africa	Country	33.4884625	-13.40819859	MWI	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	466	Mali	5	11	Western Africa	Country	-3.522016039	17.35311254	MLI	1	1			2018	68.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	478	Mauritania	5	11	Western Africa	Country	-10.33187259	20.26089546	MRT	1	1			2018	77.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	48	Bahrain	4	145	Western Asia	Country	50.5490754	26.04407747	BHR	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	480	Mauritius	5	14	Eastern Africa	Country	57.568022	-20.28581998	MUS	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	484	Mexico	5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	485	Western Asia (exc. Armenia, Azerbaijan, Cyprus, Israel and Georgia)	1			Group								2018	65.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	496	Mongolia	4	30	Eastern Asia	Country	103.0728057	46.83892054	MNG	1	1			2018	26.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	498	Republic of Moldova	4	151	Eastern Europe	Country	28.4650624	47.20236795	MDA	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	5	South America	4	419	Latin America and the Caribbean	Region								2018	79.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	50	Bangladesh	4	34	Southern Asia	Country	89.17660788	22.86961622	BGD	1	1			2018	97.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	504	Morocco	4	15	Northern Africa	Country	-6.281942841	31.8440131	MAR	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	508	Mozambique	5	14	Eastern Africa	Country	38.18479941	-14.27963886	MOZ	1	1			2018	80.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	51	Armenia	4	145	Western Asia	Country	44.93839317	40.29499741	ARM	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	512	Oman	4	145	Western Asia	Country	57.87743482	21.98805614	OMN	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	513	Europe and Northern America	2	1	World	Region								2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	514	Developed Regions	1			Group								2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	515	Developing Regions	1			Group								2018	44.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	516	Namibia	5	18	Southern Africa	Country	17.21907885	-22.13817068	NAM	1	1			2018	61.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	518	Eastern Asia (excluding Japan)	1			Group								2018	2.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	52	Barbados	5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1			2018	89.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	524	Nepal	4	34	Southern Asia	Country	83.94678863	28.25866332	NPL	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	528	Netherlands	4	155	Western Europe	Country	5.331480568	51.86728884	NLD	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	53	Australia and New Zealand	3	9	Oceania	Region								2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	54	Melanesia	3	9	Oceania	Region								2018	49.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	543	Oceania (exc. Australia and New Zealand)	3	9	Oceania	Region								2018	48.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	554	New Zealand	4	53	Australia and New Zealand	Country	170.4755673	-43.98721568	NZL	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	558	Nicaragua	5	13	Central America	Country	-85.03060315	12.84210839	NIC	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	56	Belgium	4	155	Western Europe	Country	4.660976456	50.64104975	BEL	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	562	Niger	5	11	Western Africa	Country	9.400167877	17.42143036	NER	1	1			2018	79.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	566	Nigeria	5	11	Western Africa	Country	8.097363256	9.585789025	NGA	1	1			2018	57.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	57	Micronesia	3	9	Oceania	Region								2018	76.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	570	Niue	4	61	Polynesia	Country	-169.8601693	-19.05000475	NIU	0	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	578	Norway	4	154	Northern Europe	Country	11.47846389	61.34311134	NOR	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	583	Micronesia (Federated States of)	4	57	Micronesia	Country	158.225216	6.880670092	FSM	1	1			2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	584	Marshall Islands	4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1			2018	67.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	585	Palau	4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1			2018	89.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	586	Pakistan	4	34	Southern Asia	Country	68.80479684	29.36491634	PAK	1	1			2018	79.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	591	Panama	5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	598	Papua New Guinea	4	54	Melanesia	Country	145.8587761	-6.756057077	PNG	1	1			2018	43.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	600	Paraguay	5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1			2018	94.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	604	Peru	5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	608	Philippines	4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1			2018	43.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	61	Polynesia	3	9	Oceania	Region								2018	0.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	616	Poland	4	151	Eastern Europe	Country	19.40660158	52.1226733	POL	1	1			2018	60.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	62	Central and Southern Asia	2	1	World	Region								2018	30.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	620	Portugal	4	39	Southern Europe	Country	-7.961599811	39.68509315	PRT	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	624	Guinea-Bissau	5	11	Western Africa	Country	-14.40182514	12.11760394	GNB	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	634	Qatar	4	145	Western Asia	Country	51.19152467	25.28355379	QAT	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	643	Russian Federation	4	151	Eastern Europe	Country	99.01404926	61.61899849	RUS	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	646	Rwanda	5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1			2018	97.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	674	San Marino	4	39	Southern Europe	Country	12.46329038	43.93841766	SMR	1	1			2018	58.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	678	Sao Tome and Principe	5	17	Middle Africa	Country	6.609772265	0.241554875	STP	1	1			2018	95.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	68	Bolivia (Plurinational State of)	5	5	South America	Country	-64.66224284	-16.71273412	BOL	1	1			2018	83.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	682	Saudi Arabia	4	145	Western Asia	Country	44.54763347	24.12594211	SAU	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	686	Senegal	5	11	Western Africa	Country	-14.46636926	14.35920905	SEN	1	1			2018	81.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	688	Serbia	4	39	Southern Europe	Country	20.805876	44.03145697	SRB	1	1			2018	48.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	690	Seychelles	5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1			2018	16.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	694	Sierra Leone	5	11	Western Africa	Country	-11.78306584	8.568604164	SLE	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	702	Singapore	4	35	South-Eastern Asia	Country	103.8107883	1.361009155	SGP	1	1			2018	82.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	703	Slovakia	4	151	Eastern Europe	Country	19.48495604	48.70741446	SVK	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	705	Slovenia	4	39	Southern Europe	Country	14.82209486	46.11958061	SVN	1	1			2018	60.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	710	South Africa	5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1			2018	73.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	716	Zimbabwe	5	14	Eastern Africa	Country	29.86909584	-19.00075492	ZWE	1	1			2018	89.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	72	Botswana	5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1			2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	722	Small island developing States (SIDS)	1			Group								2018	37.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	724	Spain	4	39	Southern Europe	Country	-3.554078296	40.39211472	ESP	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	729	Sudan	4	15	Northern Africa	Country	29.95650159	16.02643066	SDN	0	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	738	Sub-Saharan Africa (inc. Sudan)	1			Group								2018	72.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	746	Northern Africa (exc. Sudan)	1			Group								2018	37.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	747	Northern Africa and Western Asia	2	1	World	Region								2018	58.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	748	Eswatini	5	18	Southern Africa	Country	31.50149288	-26.56471011	SWZ	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	752	Sweden	4	154	Northern Europe	Country	14.3775338	60.60103109	SWE	1	1			2018	97.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	753	Eastern and South-Eastern Asia	2	1	World	Region								2018	13.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	756	Switzerland	4	155	Western Europe	Country	8.223158	46.96617097	CHE	1	1			2018	85.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	76	Brazil	5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	768	Togo	5	11	Western Africa	Country	0.97835765	8.532096072	TGO	1	1			2018	88.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	780	Trinidad and Tobago	5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	784	United Arab Emirates	4	145	Western Asia	Country	53.98279159	23.43322219	ARE	1	1			2018	99.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	792	Turkey	4	145	Western Asia	Country	35.42890329	38.9899684	TUR	1	1			2018	97.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	8	Albania	4	39	Southern Europe	Country	20.06660928	41.13897007	ALB	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	800	Uganda	5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	826	United Kingdom of Great Britain and Northern Ireland	4	154	Northern Europe	Country	-2.23830539	53.27691757	GBR	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	834	United Republic of Tanzania	5	14	Eastern Africa	Country	34.80521182	-6.265332606	TZA	1	1			2018	98.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	840	United States of America	4	21	Northern America	Country	-99.13830311	39.5277871	USA	1	1			2018	92.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	854	Burkina Faso	5	11	Western Africa	Country	-1.742843829	12.27491081	BFA	1	1			2018	91.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	858	Uruguay	5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1			2018	93.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	860	Uzbekistan	4	143	Central Asia	Country	63.11944558	41.77560518	UZB	1	1			2018	96.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	862	Venezuela (Bolivarian Republic of)	5	5	South America	Country	-66.15642084	7.121324748	VEN	1	1			2018	0.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	887	Yemen	4	145	Western Asia	Country	45.22389143	15.22242099	YEM	1	1			2018	64.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	894	Zambia	5	14	Eastern Africa	Country	27.850329	-14.59701056	ZMB	1	1			2018	90.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	9	Oceania	2	1	World	Region								2018	75.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
SH_ACS_PCV3	Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)	90	Solomon Islands	4	54	Melanesia	Country	160.1584117	-9.622391719	SLB	1	1			2018	84.0					WHO/UNICEF coverage estimates 2018 revision, July 2019		E	Estimated data	PT	Percentage	G	Global			
